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Extrinsic signals controlling generation of neocor-
tical neurons during embryonic life have been diffi-
cult to identify. In this study we demonstrate that
the dorsal forebrain meninges communicate with
the adjacent radial glial endfeet and influence cortical
development. We took advantage of Foxc1 mutant
mice with defects in forebrain meningeal formation.
Foxc1 dosage and loss of meninges correlated with
a dramatic reduction in both neuron and intermediate
progenitor production and elongation of the neuroe-
pithelium. Several types of experiments demonstrate
that retinoic acid (RA) is the key component of this
secreted activity. In addition, Rdh10- and Raldh2-
expressing cells in the dorsal meninges were either
reduced or absent in the Foxc1 mutants, and Rdh10
mutants had a cortical phenotype similar to the
Foxc1 null mutants. Lastly, in utero RA treatment
rescued the cortical phenotype in Foxc1 mutants.
These results establish RA as a potent, meningeal-
derived cue required for successful corticogenesis.
INTRODUCTION
Early in cerebral cortical development, lateral expansion of the
cortical neuroepithelium dominates as neuroepithelial progeni-
tors in the ventricular zone (VZ), the radial glial cells, symmetri-
cally divide with both daughter cells re-entering the cell cycle.
As corticogenesis proceeds, the radial expansion of the cortex
begins as VZ progenitors divide asymmetrically to generate
postmitotic neurons directly or intermediate progenitor cells
(IPCs) destined for additional, neuron-generating divisions in
the subventricular zone (SVZ) (Chenn and McConnell, 1995;
Miyata et al., 2004; Noctor et al., 2004, 2008). The balance oflateral and radial expansion of the neocortex depends upon
the appropriately timed switch from symmetric to asymmetric
divisions. Intrinsic (transcription factors, asymmetric protein
distribution, etc.) and extrinsic factors (growth factors and other
diffusible ligands) are implicated in the mechanics of this switch,
most of which localize to cells in cortical neuroepithelium (Chenn
and McConnell, 1995; Chenn and Walsh, 2002; Kawaguchi et al.,
2004; Li et al., 1998; Qian et al., 1997). The factors that control
the timing and continued progression of cortical neurogenesis,
however, have remained largely obscure. Here we present
evidence that all-trans retinoic acid (atRA) released from the
meninges is involved in the decision of neuroepithelial cells to
generate IPCs and neurons.
atRA is a hormone derived from vitamin A (retinol) that signals
via binding to its nuclear retinoic acid receptors (RAR) and reti-
noid X receptors (RXR) (Chambon, 1996). atRA synthesis is a
two-step process that requires retinol dehydrogenases (Rdh)
and retinaldehyde dehydrogenases (Raldh1, 2, and 3) (Napoli,
2004; Ross et al., 2000). Raldh2 is critical for atRA synthesis in
the developing embryo; Raldh2/ embryos are almost entirely
devoid of atRA signaling and die around E9.5–E10.5 with defects
in head, trunk, and heart development (Niederreither et al., 1999).
Adequate atRA production during development also depends
upon the activity of Rdh10 as demonstrated by the dramatic
reduction in atRA levels in theRdh10 hypomorph, which displays
head, limb, and organ defects typical of severe atRA deficiency
(Sandell et al., 2007).
Early forebrain morphogenesis requires atRA signaling (Ribes
et al., 2006), and at these early patterning stages the source of
atRA is the adjacent forming eye and nasal pits that express
Raldh2 and Raldh3 (Anchan et al., 1997; Molotkova et al.,
2007). Even as these rich sources of atRA become spatially
disparate from the dorsal forebrain, there is evidence of strong
and very specific atRA signaling in the cortical radial glial progen-
itors. This has been perplexing largely because even though
RARa and RXRa, b are expressed in the cortical neuroepithelium
(Dolle et al., 1994; Ruberte et al., 1993), the enzymes required forCell 139, 597–609, October 30, 2009 ª2009 Elsevier Inc. 597
Figure 1. Foxc1 Gene Dosage Correlates with Severity of Dorsal Forebrain Phenotype
(A) E14.5 Foxc1+/+, Foxc1h/h, Foxc1h/l, and Foxc1l/l forebrains labeled with Tuj1 (green) and Ki-67 (red).
(B) Quantification of the dorsal forebrain length in WT and Foxc1h/h, Foxc1h/l, and Foxc1l/l brains.
(C) Nissl stains of E18.5 Foxc1h/h, Foxc1 h/l, and Foxc1l/l mutant brains. Arrows indicate cortical dysplasia.
Scale bars = 500 mm (A) and 1 mm (C). * and # denote statistical significance (p < 0.05) from WT and Foxc1h/h, respectively. Error bars depict ± the standard error
of the mean (SEM).atRA synthesis are not expressed in the dorsal forebrain and,
consequently, the functional role of atRA during corticogenesis
has been largely neglected. In this study we show that mice
that fail to form complete forebrain meninges, Foxc1 mutants
(Vivatbutsiri et al., 2008; Zarbalis et al., 2007), have major defects
in the switch from lateral VZ expansion to neuronogenic radial
expansion of the cortex, and this is due to a loss of meningeal-
derived atRA.
RESULTS
Reduction or Loss of Foxc1 Leads to Lateral Expansion
of the Dorsal Forebrain and Decreased Neuron
Production
We previously identified a hypomorphic allele of the Foxc1 gene
(Foxc1hith) with perinatal cortical dysplasia due to defects in the
basement membrane and meningeal differentiation (Zarbalis
et al., 2007). These Foxc1 hypomorphs displayed an earlier
cortical phenotype characterized by a longer dorsal forebrain.
To fully characterize this phenotype we analyzed an allelic series
of Foxc1 mutants: Foxc1 hypomorphs (Foxc1hith/hith; Foxc1h/h),
a hypomorph-null hybrid (Foxc1hith/lacZ; Foxc1h/l), and Foxc1
null embryos (Foxc1lacZ/lacZ; Foxc1l/l) (Kume et al., 1998). At
E14.5, the dorsal forebrain was significantly longer (p < 0.05;
Figure 1B) and appeared thinner in all three Foxc1 mutants
compared to the wild-type (WT) with the phenotype worsening
with decreased gene dosage (Figure 1A). At E10.5 there was
no cortical phenotype in any of the Foxc1 mutant lines
(Figure S1A available online); however, by E12.5 dorsal forebrain
lengthening was evident (Figure S1B). The extended cortical wall
translated into cortical dysplasia that ranged from moderate to
severe at E18.5 (Figure 1C).598 Cell 139, 597–609, October 30, 2009 ª2009 Elsevier Inc.The lateral expansion of the neuroepithelium in the Foxc1
mutants suggests a predominance of symmetric divisions. We
looked at this indirectly by analyzing expression of atypical-
PKCl (aPKCl) and Par3, proteins that are enriched at the apical
membrane of neuroepithelial cells undergoing symmetric divi-
sions (Costa et al., 2008). In WT brains at E14.5, aPKCl was
present at low levels in the apical membrane of VZ progenitors
along the ventricular surface with a few areas of bright apical
staining (Figure 2A). In all three Foxc1 mutant cortices, aPKCl
levels were significantly (p < 0.05) elevated (Figures 2A and
2C). Although less abundant, apical Par3 was also significantly
(p < 0.05) increased in all Foxc1 mutants with the Foxc1l/l
mutants having the largest increase (Figures 2B and 2C).
We next measured the output of asymmetric divisions,
neurons and IPCs. A bromodeoxyuridine (BrdU)/Ki-67 cell-cycle
exit assay was used to examine neuron generation. BrdU-
positive (BrdU+) but Ki-67-negative (Ki-67) cells were counted
as cells that had exited the cell cycle. In WT cortex, a band of
BrdU+/Ki-67 cells was apparent above the SVZ (Figure 2D;
above dotted line). All three mutants had significantly (p < 0.05)
reduced BrdU+/Ki-67 populations though the Foxc1h/h was
less affected than the Foxc1h/l and Foxc1l/l mutants (Figures
2E–2H). Tbr2 immunolabeling was used to examine the IPC
population. Significant (p < 0.05) reductions in Tbr2+ cell number
were observed in all three Foxc1 mutants (Figures 2I–2M) with
the Foxc1 null having the most severe deficit (Figure 2L). At
E14.5, the decrease in cell-cycle exit (and presumably, to a lesser
extent, the decrease in IPCs) correlated with a decrease in
Ctip2+, postmitotic neurons in the Foxc1 mutants (Figures
2N–2Q).
To determine the consequences of the decreased production
of neurons and IPCs in older embryos, we examined expression
of a deep (Ctip2) and a superficial cortical layer marker (Brn2) at
E18.5. In all the Foxc1 mutants (Figures 2S–2U), the cortical
layers were disorganized (Figure 2R). Like at E14.5, the Ctip2+
cell population was progressively and dramatically reduced in
number according to genotype. The Brn2 population in the VZ,
SVZ, and upper cortical layers was even more affected with
very few Brn2+ cells present in the superficial cortex of the
Foxc1l/l brain (Figure 2U).
The decrease in neuron output and IPC production in the
Foxc1 mutants could be caused by defects in forebrain
patterning or the VZ progenitor population, a change in cell
cycle, or radial glia detachment. Expression of dorsal fore-
brain-restricted Pax6 and Tbr2 highlighted the elongation of
the dorsal forebrain, but both were present in a normal spatial
distribution (Figure S1C). Closer examination of Pax6, expressed
by neuronal progenitors in the VZ, showed that the thickness of
the Pax6+ layer appeared normal in all the Foxc1 mutants
(Figure S1D). The Pax6 expression coupled with the increased
length of the mutant cortices (and thus the neuroepithelium)
provides additional evidence that the neuronal progenitor popu-
lation is increased in the Foxc1 mutants. Cell-cycle analysis in
the VZ (S phase and total length of the cell cycle) at E14.5
showed no overt differences in either parameter between WT
and any of the Foxc1 mutants (Figure S1E). We also found no
evidence of increased apoptotic cell death at E14.5 or E18.5
(data not shown). Finally, because of previous work describing
basement membrane disruptions and radial glial detachment in
the Foxc1h/h brains at E18.5 (Zarbalis et al., 2007), we examined
laminin and nestin expression in the Foxc1l/l at E13.5. At this age,
the dorsal forebrain phenotype was apparent, but there was no
evidence of disruption in the basement membrane in the
Foxc1l/l cortex and the radial glial processes appeared well orga-
nized (Figures S1F and S1G). In both WT and Foxc11/l cortices,
the radial glial endfeet colocalized with laminin at the glia limitans
(Figure S1G, insets) and high-power, confocal images did not
reveal radial glial detachment in the Foxc1l/l cortex (Figure S1H).
The Dorsal Forebrain Meninges Are Reduced or Absent
in Foxc1 Mutants
The meninges are directly opposed to the radial glial endfeet
of the VZ progenitors, thus making them a potential root cause
of the cortical phenotype in the Foxc1 mutants. To examine the
distribution of meningeal fibroblasts in the Foxc1 mutants, we
used an antibody that recognizes Zic protein family members
that are expressed by meningeal fibroblasts (Inoue et al.,
2008). In the E14.5 WT brain, Zic+ meningeal cells completely
surrounded the forebrain (Figure 3A). Zic+ meningeal cells as
well as Zic+ Cajal-Retzius cells in the marginal zone of the brain
were evident at higher magnification (Figure 3A0). The Zic+
meningeal cells were present in ventral and lateral meninges of
the Foxc1h/h brain, but bright, Zic+ meningeal cells were absent
in the most dorsal meninges (Figures 3B and 3B0). In the
Foxc1h/l brain, Zic+ meningeal cells covered only a short portion
of the lateral cerebral wall (Figures 3C and 3C0). The Zic+
meninges in the Foxc1l/l were completely missing over the dorsal
forebrain but were present ventrally (Figures 3D and 3D0). To
confirm that the Zic labeling reflected a loss of meninges and
not just the loss of Zic expression, we looked at b-galactosidase(b-gal) activity in Foxc1l/+ and Foxc1l/l. In the Foxc1l/+, darkly
labeled b-gal+ meningeal cells were present in a continuous layer
around the brain and more lightly labeled vascular cells were
evident in brain tissue (Figures 3E and 3E0). In contrast, the darkly
labeled b-gal+ meningeal cells in Foxc1l/l brains ended below the
ventral forebrain leaving only b-gal+ vascular cells in the supra-
cortical mesenchyme (Figures 3F and 3F0).
TheMeninges Secrete a Diffusible Factor that Promotes
Cell-Cycle Exit
The progressive decrease in neuron and IPC production as
meningeal coverage declines suggests that the cortical pheno-
type in the Foxc1 mutants reflects a graded loss in a meningeal
signal that influences the behavior of radial glial progenitors. To
test this idea we performed two types of rescue experiments
using E13.5 forebrain explants (Figure 4A): (1) transplantation
of Foxc1h/h forebrain into normal meninges and (2) coculturing
of Foxc1h/h explants with Foxc1+/Zic+ meningeal cells (Figures
S2A and S2B) that conditioned the shared media.
Consistent with the in vivo experiments, untreated (i.e., no
transplantation and no conditioned media) Foxc1h/h forebrain
explants had a significantly (p < 0.05) reduced proportion of
BrdU+/Ki-67 cells (Figures 4B, 4C, and 4N). Meningeal trans-
plantation did not affect cell-cycle exit in the Foxc1+/ slices
(Figures 4D and 4H); however cell-cycle exit was improved in
the Foxc1h/h forebrain explants transplanted into the meningeal
‘‘ghosts’’ derived from Foxc1+/ forebrain (Figures 4E and 4N).
Similarly, coculturing Foxc1h/h forebrain explants with meningeal
cells also significantly (p < 0.05) increased the proportion of
BrdU+/Ki-67 cells but did not affect cell-cycle exit in the
Foxc1+/ forebrain explants (Figures 4F, 4G, and 4N).
atRA Is the Bioactive Component of Meningeal
Conditioned Medium and atRA Biosynthetic
Enzymes Are Missing from the Meninges
in the Foxc1 Mutant Mice
atRA is a potent neuronal differentiation signal and enzymes
required for atRA synthesis are expressed in the meninges,
making it an attractive candidate molecule as the meningeal
factor. Treatment with atRA (10 mM) did not affect cell-cycle
exit in the Foxc1+/ explants but increased cell-cycle exit in the
cortex of Foxc1h/h explants (Figures 4H, 4I, and 4N). We next
determined whether atRA is a required component of meningeal
conditioned media for rescue of Foxc1h/h slices. We cocultured
meningeal cells and slices in media with B27 supplement that
lacked vitamin A (B27-VA), the precursor used to make atRA.
In addition, we cultured slices in meningeal conditioned media
that had been exposed to sunlight to deplete the atRA. To
confirm that atRA was decreased, atRA levels were assayed
by liquid chromatography tandem mass spectrometry (LC/MS/
MS) (Kane et al., 2005, 2008) (Figure S2C). B27-VA conditioned
media and atRA-depleted conditioned media did not alter
cell-cycle exit in Foxc1+/ slices (Figures 4J, 4L, and 4N), but
both failed to rescue the cell-cycle exit phenotype in the
Foxc1h/h slices (Figures 4K, 4M, and 4N). We did, however,
notice an increased number of pyknotic nuclei in some Foxc1+/
and Foxc1h/h explants cultured in meningeal conditioned media
exposed to light (data not shown), which indicated increased cellCell 139, 597–609, October 30, 2009 ª2009 Elsevier Inc. 599
Figure 2. Defect in Switch from Symmetric to Asymmetric Divisions in the Neuroepithelium of Foxc1 Mutants
(A) aPKCl immunostaining in WT, Foxc1h/h, Foxc1h/l, and Foxc1l/l cortical neuroepithelium at E14.5.
(B) Par3 immunostaining (green) in the apical membrane of E14.5 WT, Foxc1h/h, Foxc1h/l, and Foxc1l/l cortical neuroepithelial cells with (right panels) and without
(left panels) DAPI nuclear stain (blue).
(C) Quantification of fluorescent intensities of aPKCl (top) and Par3 (bottom) in WT and Foxc1 mutants.600 Cell 139, 597–609, October 30, 2009 ª2009 Elsevier Inc.
death. Cell-cycle exit in Foxc1+/ explants in this treatment condi-
tion did not differ from unconditioned media, indicating that the
change in cell viability was not influencing this parameter.
We next looked at the expression of Raldh2 and Rdh10, two
enzymes critical for atRA synthesis, in WT and Foxc1 mutant
meninges. In situ hybridization in E14.5 WT tissue showed that
Raldh2 and Rdh10 signal was very high in the meninges, with
no expression of Raldh2 evident in the dorsal forebrain and a
very low level of expression of Rdh10 in the cerebral wall (Figures
5A, 5A0, 5E, and 5E0). Unlike Raldh2, Rdh10 signal was also
present in the choroid plexus and in the cortical hem in WT,
Foxc1h/h, and Foxc1h/l brains; this is consistent with previous
analysis of Rdh10 expression in the embryonic brain (Romand
et al., 2008). In the Foxc1h/h brain, Raldh2 and Rdh10 expression
wasdetectable in ventral and lateral meninges, but the expression
intensity was patchy in the dorsal meningeal areas (Figures 5B,
(D–H) Representative staining from BrdU (red)/Ki-67 (green) cell-cycle exit assay; dotted line demarcates BrdU+/Ki-67 cells in the intermediate zone (IZ) of WT (D)
Foxc1h/h (E), Foxc1h/l (F), and Foxc1l/l (G) cortices. The percentage of exited cells was quantified for WT and Foxc1 mutants (H).
(I–M) Tbr2 immunostaining of IPCs in the VZ and SVZ of WT (I), Foxc1 h/h (J), Foxc1 h/l (K), and Foxc1l/l (L) cortices. Quantification of Tbr2+ cells in all genotypes (M).
(N–Q) Ctip2 (green) in E14.5 (N) WT, (O) Foxc1 h/h, (P) Foxc1h/l, and (Q) Foxc1l/l mutants. Dotted line denotes ventricular surface.
(R–U) Brn2 (green) and Ctip2 (red) colabeling in E18.5 (R) WT, (S) Foxc1 h/h, (T) Foxc1 h/l, and (U) Foxc1l/l mutants.
Scale bars = 25 mm (A and B), 100 mm (D–G, I–L), and 200 mm (N–U). * and ** denote a statistically significant difference (p < 0.05) from WT and both WT and
Foxc1h/h, respectively. Abbreviations: CP, cortical plate; IZ, intermediate zone; SVZ, subventricular zone; VZ, ventricular zone. Error bars depict ± SEM.
Figure 3. The Dorsal Forebrain Meninges Fail to
Form Completely in the Foxc1 Mutants
Low-magnification (A–D) and high-magnification (A0–D0)
images of Zic immunostaining in WT, Foxc1h/h, Foxc1h/l,
and Foxc1l/l E14.5 heads. Arrowheads in (A0), (B0), and
(C0) indicate Zic+ Cajal-Retzius cells and open arrows in
(A0) indicate Zic+ cells in the cortical vasculature. The
endpoint of the meninges (denoted by an asterisk in B,
C, and D) is shown in higher magnification view in (B0),
(C0), and (D0) and indicated by a dotted line. Lightly labeled
Zic+ vascular cells persist in the residual mesenchyme in
all mutants (open arrows in B0).
Low-magnification (E and F) and high-magnification
(E0 and F0) images of x-gal staining in E14.5 Foxc1+/l and
Foxc1l/l. Higher-magnification images show lightly labeled
b-gal+ cells in the cortical vasculature (E0 and F0; arrows).
Scale bars = 500 mm (A–D , E, and F) and 100 mm (A0–D0,
E0, and F0).
5B0, 5F, and 5F0). In addition, the intensity of the
Raldh2 and Rdh10 signal was reduced in the
Foxc1h/h meninges, though the intensity levels
were similar to WT in the facial mesenchyme.
Even fewerRdh10- and Raldh2-expressing cells
surrounded the brains of the Foxc1h/l (Figures
5C, 5C0, 5G, and 5G0) and Foxc1l/l (Figures 5D,
5D0, 5H, and 5H0) mutants, though there was
expression in the residual, midline meninges.
Temporal and Spatial Appearance
of Raldh2+ Cells in the Meninges
Correlates with Neurogenic Gradient
To test whether the onset of the Foxc1 mutant
cortical phenotype (E12.5 in the Foxc1h/h;
E11.5 in the Foxc1h/l and Foxc1l/l mutants; data not shown) is
temporally and spatially related to the normal appearance of
Raldh2+ cells in the meninges, we examined Raldh2 protein
expression in WT brains on E11.5, E12.5, and E14.5. At E11.5,
no Raldh2 staining was present in the meninges but was evident
around the developing nasal cavities (Figure 6A). By E12.5,
Raldh2+ cells were present in the ventral meninges and a few
Raldh2+ cells were present in the lateral but not dorsal meninges
(Figures 6B and 6B0). This suggests that Raldh2+ cells appear
in a lateral to medial gradient, which is the same distribution
as the gradient for neuron production during this same
period. By E14.5 the entire meninges contained Raldh2+ cells
(Figure 6C). Colabeling of Raldh2 with Foxc1 or Foxc2 in the
dorsal meninges showed that the Raldh2+ cells represent a
subset of cells within the Foxc1+ meninges (Figure 6D). Foxc2,
a close homolog of Foxc1 that localizes to cells in the duraCell 139, 597–609, October 30, 2009 ª2009 Elsevier Inc. 601
Figure 4. Cell-Cycle Exit Defect in Foxc1h/h Explants Is Rescued by Exposure to Secreted Cues from Meninges and atRA
(A) Depiction of in vitro explant preparations: meningeal transplantation preparation (left diagram) and coculturing of Foxc1h/h mutant explants in media condi-
tioned by WT meninges (right diagram).
(B–M) BrdU (red) and Ki-67 (green) double-immunolabeling of Foxc1+/ and Foxc1h/h forebrain explants from the following treatment conditions: untreated Neuro-
basal media (NB) (B and C), meningeal transplantation (MT) (D and E), meningeal conditioned media (MCM) (F and G), atRA (H and I), MCM containing B27-VA
supplement (J and K), and atRA-depleted MCM (L and M). Dotted line demarcates transition from proliferative and postmitotic zones in the cerebral wall. Unless
noted otherwise, all media contained B27+VA supplement.
(N) Quantification of the percent BrdU+/Ki-67 in each explant treatment condition.
Scale bars = 50 mm. * indicates statistical significance from untreated Foxc1+/ explants (p < 0.05). Error bars depict ± SEM.(Zarbalis et al., 2007), did not colabel with Raldh2+ cells in the
dorsal meninges (Figure 6E). In the ventral meninges, Foxc1
and Foxc2 both colocalized with meningeal Raldh2+ cells
(Figures 6F and 6G).
Cortical Expansion Phenotype in Rdh10
Hypomorph Mutants
To assess the requirement of atRA for corticogenesis, we used
an Rdh10 hypomorphic mutant that was recovered from the
same ENU mutagenesis screen as the Foxc1h/h mice (Zarbalis602 Cell 139, 597–609, October 30, 2009 ª2009 Elsevier Inc.et al., 2004) and that is viable to E16.5 (A.M.A. and A.P., unpub-
lished data). These mice have eye, face, and limb defects that are
very similar to a published Rdh10 hypomorphic allele that is only
viable until E13.5 (Sandell et al., 2007). Similar to the Foxc1l/l
cortical phenotype (Figure 6J), the dorsal forebrain of the
Rdh10 mutant was much longer than that of its WT littermate
at E13.5 (Figures 6H–6I), and the thickness of the postmitotic,
Tuj1+ layer was reduced (Figures 6K–6M). Unlike the Foxc1l/l,
the Zic+ meninges appear intact in the Rdh10 mutant (Figure S3).
Analysis of Brn2 and Ctip2 at E16.5 revealed a thinned cortex
in the Rdh10 mutant with very few Ctip2 and Brn2+ cells present
(Figures 6N and 6O). The reduction in upper and lower cortical
layer neurons was comparable to Foxc1l/l at E16.5 although
the cortical layering was disorganized in the Foxc1 mutant
(Figure 6P).
To assess whether atRA is reduced in the Foxc1l/l mutant
brains, total forebrain meninges or dorsal forebrain were
collected separately from E14.5 Foxc1l/l brains and Foxc1+/ litter-
mates. Meningeal tissue collected from the Foxc1l/l brains con-
tained significantly less atRA (20%; p < 0.05) than littermate
controls (Figure 6Q). The decline was likely not greater because
it was difficult to only collect the tissue surrounding the cortex,
thus Raldh2/Rdh10-expressing meninges from the midline
and ventral forebrain Foxc1l/l meninges were included in the
tissue dissected. An even greater decrease in atRA was
observed in the Foxc1l/l cortices (50%; p < 0.05). In addition,
there was 3-fold more atRA in the meninges than in the cortex
(0.74 mmol/mg tissue versus 0.28 mmol/mg tissue in Foxc1+/
samples).
Figure 5. Expression of Raldh2 and Rdh10
in Wild-Type and Foxc1 Mutant Meninges
Low-magnification (A–D) and high-magnification
(A0–D0 ) images of in situ hybridization for Raldh2
on E14.5 WT and Foxc1 mutant heads. The
endpoint of meningeal Raldh2 signal is indicated
by an arrow in (B)–(D). Red arrows in (B)–(D) indi-
cate Raldh2 signal in the midline correlating to
residual meninges.
Low-magnification (E–H) and high-magnification
(E0–H0) images of in situ hybridization for Rdh10
on E14.5 WT and Foxc1 mutant heads. The arrows
in (F)–(H) indicate the end of Rdh10 signal in the
Foxc1 mutants (magnified in F0–H0 ). Red arrows
in (F) and (G) indicate Rdh10 signal in the cortical
hem and choroid plexus of Foxc1h/h and Foxc1h/l
animals; it is not seen in the hem and choroid
plexus of (H) as these structures are not present
in the Foxc1l/l at this level.
Scale bars = 50 mm (A0–H0) and 500 mm (A–H).
Arrows in (A0)–(H0) indicate cells with positive
signal.
In Vivo Rescue of Foxc1 Mutants
by atRA Treatment
To examine in vivo rescue of the cortical
phenotype, we injected 20 mg/kg atRA
once daily into pregnant mice carrying
Foxc1h/h, Foxc1h/l, or Foxc1l/l mutant
embryos from E10.5 to E13.5 and
collected them on E14.5. The atRA
dosing regimen did not have any obvious
effect on WT brains but led to a dramatic
reduction in the dorsal forebrain length in
the Foxc1h/h and Foxc1h/l mutants as
compared to untreated mutants (Figures
7A–7F). Staining for Pax6 and Ctip2
untreated and atRA-treated brains high-
lights the decrease in the length of the
neuroepithelium and increased thickness
in the Ctip2+, postmitotic population in the atRA-treated Foxc1
mutants. Higher-magnification images of Ctip2 staining showed
that atRA treatment did not affect generation of Ctip+ neurons
in WT cortices but increased the number of Ctip2+ cells in the
cerebral wall of Foxc1h/h and Foxc1h/l mutants as compared to
untreated mutants (Figures 7I–7K). In the three litters analyzed,
Foxc1h/l mutants showed a range of dorsal forebrain rescue (Fig-
ure S5A). Interestingly, the 20 mg/kg atRA dose did not rescue
the cortical expansion phenotype in the Foxc1l/l mutant (data
not shown). A higher dose of atRA (30mg/kg) reduced the length
of the dorsal forebrain and increased the Ctip2+ population as
compared to the untreated Foxc1l/l mutant (Figures 7G, 7H,
and 7L). Unfortunately, the higher dose of atRA also appeared
to be toxic for the Foxc1l/l mutant embryos; in these brains,
tissue integrity was compromised, the cells in the head and brain
tissue appeared rounded, and there was activated caspase-3 in
the head mesenchyme (Figure S5B). Zic immunolabeling in WT
(Figures S4A and S4A0), Foxc1h/l (Figures S4B and S4B0), and
Foxc1l/l (Figures S4C and S4C0) atRA exposed brains ruled outCell 139, 597–609, October 30, 2009 ª2009 Elsevier Inc. 603
that the rescue of the Foxc1mutants was the result of an effect of
atRA on the formation of the meninges.
To quantify the atRA rescue, the length of the dorsal forebrain
and the number of Ctip+ cells in a defined field were analyzed
in atRA-treated WT and Foxc1 mutant brains and compared
to nontreated (NT) samples. atRA treatment significantly
decreased (p < 0.05) the length of the dorsal forebrain (Figure 7M)
and significantly increased (p < 0.05) the number of Ctip2+ cells
(Figure 7N) in all Foxc1mutants as compared to their NT counter-
parts. atRA-treated Foxc1l/l forebrains remained significantly
Figure 6. Raldh2 Expression in the DevelopingMeninges and
Phenotype of Rdh10 Mutant
(A–C) Raldh2 (green) expression at E11.5 (A), E12.5 (B), and (C) E14.5.
Higher magnification of the box in (B) shows the leading edge of
Raldh2 in the meninges (B0; arrows).
(D–G) High-magnification image of dorsal WT meninges at E14.5
showing expression of Foxc1 (green) in the nucleus of Raldh2 (red)
expressing cells (D; arrows). Foxc2 is expressed in meningeal cells
above the Raldh2 cell layer but Raldh2+ cells in this area are not
Foxc2+ (E; arrows). In the ventral meninges, Raldh2+ cells express
both Foxc1 (F; arrows) and Foxc2 (G; arrows).
(H–J) Tuj1 (green) and Ki-67 (red) double-immunolabeling of E13.5 WT
(H),Rdh10mutant (I), and Foxc1l/l (J) brains highlights the similarities in
the dorsal forebrain phenotype in the two mutants.
(K–P) High-magnification images of Tuj1 (green; K–M) or dual Ctip2
(red) and Brn-2 (green; N–P) immunolabeling in E13.5 and E16.5 WT
(K and N) Rdh10 mutant (L and O) and Foxc1l/l mutant (M and P).
(Q) Graph depicting atRA levels in the total forebrain meninges and
cortices of Foxc1+/ and Foxc1l/l embryos at E14.5. Values are reported
as percent of atRA in Foxc1+/ tissue.
Scale bars = 50 mm (D, E, K, L, and M), 100 mm (N–P), 200 mm (F and G),
and 500 mm (A–C, H–J). * indicates statistical significance from
Foxc1+/ (p < 0.05). Error bars depict ± SEM.
longer (p < 0.05) (Figure 7M) and had significantly fewer
(p < 0.05) Ctip2+ cells than WT brains. In addition, atRA-
treated Foxc1h/h and Foxc1h/l mutants showed significant
improvement in neuron (Figures S5C and S5D) and IPC
(Figures S5E and S5F) production as well as aPKCl and
Par3 expression (Figures S5G and S5H) compared to
untreated mutants.
To test whether atRA supplementation also improves
production of later generated neurons, we fed pregnant
mice an atRA-enriched diet that allowed longer treatment
times. The diet was less teratogenic than daily injections
of atRA and the atRA-diet rescued Foxc1h/h and Foxc1h/l
mutants at E14.5 to the same extent as the injections
(data not shown). The Foxc1h/l mutant exposed to atRA
from E10–E16.5 had a notable shorter, thicker cortex
than the untreated mutant (Figure 7O). Analysis of
Ctip2+ and Brn2+ in the neocortex confirmed a substantial
increase in both early and late-generated neurons in
the atRA-exposed Foxc1h/l mutant (Figure 7P). The
lengthening of the neocortex was also improved in the
atRA exposed (E10–E18.5) Foxc1h/h brain (Figure 7Q) as
was generation of both Brn2+ and Ctip2+ neurons
(Figure 7R); however there was still evidence of laminar
disorganization in the atRA-exposed Foxc1h/h cortex.
This is consistent with the cortical dysplasia observed in
E18.5 Foxc1h/h mutants caused by meningeal/basement
membrane defects that are likely present in the atRA-treated
mutants.
DISCUSSION
Controlling the Timing and Progression of Neocortical
Neurogenesis
The development of the mammalian neocortex is remarkable in
that a cohort of progenitors undergoes multiple rounds of604 Cell 139, 597–609, October 30, 2009 ª2009 Elsevier Inc.
division to produce a precisely defined set of distinct neuronal
subtypes that occupy disparate cellular layers. The overall size
of the cerebral cortex is controlled by the number of neuroepithe-
lial progenitors generated via symmetric divisions and by the
number of neurons that are generated from each progenitor via
asymmetric divisions during the period of embryonic neurono-
genesis (Caviness et al., 1995).
Though several proteins have been identified as central in the
mechanics of the switch from symmetric to asymmetric divi-
sions, few candidates have been identified that fit the criteria
of a trigger event that signals to the VZ progenitors to begin
undergoing neuronogenic divisions. The meninges are an ideal
source of this signal, in part because their close proximity to
the radial glial endfeet allows for a potent, short-range signal
that need not influence IPC proliferation events (IPCs do not
make contact with the glial limitans) or maturation of projection
neurons in the cortical plate. Further, we have shown that the
maturation of the meninges is such that the cells that make
meningeal-derived atRA appear in a lateral-to-medial gradient
as predicted for a signal responsible for the neurogenic gradient.
From an evolutionary perspective, it is possible that the expan-
sion of the neuroepithelium that is required to make a larger
neocortex relies not only on events intrinsic to the neocortical
neuroepithelium but also upon the timing of meningeal develop-
ment, specifically the arrival of atRA-producing cells.
From our work and the work of others, a model of atRA in fore-
brain development emerges. During forebrain patterning and the
earliest stages of cortical development prior to the arrival of
Raldh2/Rdh10 cells in the meninges, atRA diffuses from the
Raldh2, 3 enriched facial mesenchyme. Once corticogenesis
proceeds in earnest, a more local source of atRA in the form of
Raldh2/Rdh10 meningeal cells is required for neurogenic stimu-
lation as the developing cortex is now spatially separated from
atRA sources in the face (Figure 7S).
The Meninges Is a Signaling Center Regulating Brain
Development
The idea of the meninges as a source of developmental cues is
not a new concept. Previous studies showed that Cxcl12, a che-
mokine ligand, produced by the innermost layer of the meninges
regulates the positioning of cortical interneurons and Cajal-
Retzius cells by acting as a chemoattractant during corticogen-
esis (Borrell and Marin, 2006; Li et al., 2008; Lopez-Bendito et al.,
2008; Paredes et al., 2006). The outermost layer of the meninges,
the dura, is involved in the formation of the skull by releasing
TGF-b family members and FGF-2 to induce bone formation
(Ito et al., 2003; Mehrara et al., 1999). That we have identified
atRA as a key component of the neurogenic signal produced
by the middle meningeal layer now implicates all layers of the
embryonic meninges as sources of cues that regulate the devel-
opment of surrounding tissues. Further, the cranial neural crest
origin of the meninges, a key source of the tremendous diversity
of head structures seen in vertebrates (Le Douarin et al., 2007;
Santagati and Rijli, 2003), suggests that the meninges may be
an additional component of this evolutionary paradigm.
There is a possibility that the phenotype of the Foxc1 mutants
may be related to the vascular phenotype that is seen in these
mice. For example, endothelial cells secrete factors like FGFthat stimulate embryonic neural stem cells to undergo
symmetric, self-renewing divisions (Shen et al., 2004). Foxc1,
however, is expressed in pericytes and smooth muscle cells in
the meninges and cortical vasculature but not by endothelial
cells (J.A.S. and S.J.P., unpublished data). Also, the vascular
defects do not appear until after the cortical phenotype is
apparent in the Foxc1 mutants. There may be a pericyte-derived
factor that influences neurogenesis that is not produced in the
absence of Foxc1. This is unlikely given that mouse mutants
that have severely reduced pericyte numbers in the developing
cortex do not have a cortical phenotype (Hellstrom et al., 2001).
atRA as a Sequential Inducer of Forebrain Development
atRA is an ideal molecule to induce neuronogenic divisions
because it is a potent neural differentiation signal. Treatment of
embryonic stem cells with atRA triggers upregulation of a series
of neural-specific genes that ultimately results in the production
of both neurons and glia (Maden, 2001). Because it is such
a strong neuronal induction cue, restricting atRA production to
the meninges may prevent inappropriate atRA signaling. In
support of this, CRABP I, II and CRBP1, proteins that bind and
chaperone atRA and retinol, respectively (Napoli, 1999), are
expressed by the meninges during development, when they
may further titrate atRA exposure of the radial glial endfeet
(Ruberte et al., 1993). In addition, CRABP II is expressed in the
VZ of the developing cortex (Ruberte et al., 1993), where it likely
aids in the intracellular transport of atRA to the nucleus through
the cytoplasm of the radial glial fiber. This model of restricted
atRA exposure has already been established in the hindbrain.
atRA signaling in hindbrain is limited to migrating cells and fixed
structures adjacent to the regions of Raldh2-enriched meninges
(Zhang et al., 2003).
Despite the fact that atRA is a well-recognized cue for
neuronal differentiation, a function for this molecule in neocor-
tical development has been difficult to establish because the
key mutants in the signaling pathways exhibit phenotypes at
earlier stages of forebrain development and die before cortico-
genesis begins (Ribes et al., 2006). However, although not noted
in the original publication, in RARa/g double-knockout the dorsal
forebrain is elongated in a manner similar to the Rdh10 and
Foxc1l/l mutants (Figure 2h in Lohnes et al., 1994). Also, vitamin
A deprivation from E11 to E13 results in a reduction in postmi-
totic neurons in the telencephalon (Dickman et al., 1997). These
data are consistent with our analysis of the cortical phenotype
in the Rdh10 mutants. The Rdh10 mutants appear to have
meninges covering the cortex that presumably produce and
secrete other meningeal-derived cues like CXCL12 but are not
capable of producing normal levels of atRA. This provides further
evidence that atRA is the primary signal from the meninges regu-
lating corticogenesis.
Transgenic retinoic acid response element-lacZ reporter mice
(RARE-lacZ) are frequently used to assess retinoid signaling in
the developing embryo and have a strong b-gal signal in radial
glial cells in the forebrain (Haskell and LaMantia, 2005; Luo
et al., 2004). Our analysis of the RARE-hsp68lacZ transgene
(Rossant et al., 1991) in Foxc1+/l and Foxc1l/l brains revealed
that most of the b-gal observed in the dorsal forebrain persists
from transgene activation from an earlier developmental stageCell 139, 597–609, October 30, 2009 ª2009 Elsevier Inc. 605
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(data not shown). Indeed, Raldh2/;RARE-lacZ embryos, when
given atRA to avoid early lethality, show persistent b-gal activity
in the dorsal forebrain potentially resulting from early exposure
to atRA produced from Raldh3-expressing olfactory placodes
(Niederreither et al., 2002). In light of all the evidence implicating
atRA in cortical development, our observation of low RARE-lacZ
activation (as assayed by lacZ in situ probe) in the Foxc1+/l
cortices is not an accurate picture of the role of atRA signaling
during corticogenesis and thus is not useful in assessing whether
atRA signaling is altered in the Foxc1l/l mutants. The low RARE-
lacZ activation, despite the presence of atRA in the cortex, may
be a result of the high levels of RARE repressive activity in the
developing cortex, even in the presence of atRA which normally
relieves transcriptional repression of RAREs by RAR/RXR heter-
odimers (Liao et al., 2005). Also, the two RARE-lacZ transgenes
(RARE-hsp68lacZ [Rossant et al., 1991] and RARE/tk/b-gal [Bal-
kan et al., 1992]) both employ the RARE of the RARb2 gene
promoter. Previous studies showed that specific RAR/RXR
cofactors are intimately involved in both the activation and
repression of the RARE specific to the RARb2 promotor (Folkers
et al., 1998). Thus the absence or overabundance of these cofac-
tors in the forebrain likely influence the RARE-lacZ transgene
activation and could lead to false positives and negatives with
regard to retinoid signaling.
Summary
The Foxc1 mutants provide a unique opportunity to assess fore-
brain development in which a very discrete head structure, the
forebrain meninges, is reduced or completely absent. As a result,
we were able to identify a previously unknown role for the
meninges: promotion of cortical neuron generation through
release of a bioactive molecule. The identification of atRA as
the bioactive signal from the meninges is compelling, providing
impetus to pursue the details of atRA signaling in the VZ and to
determine the mechanism of control of the neuronogenic deci-
sion by atRA at this time.
EXPERIMENTAL PROCEDURES
Animals
Details of animal breeding, atRA treatment, and genotyping are found in the
Supplemental Data.
Cell-Cycle Exit, Tbr2, Ctip2, and Cerebral Length Analysis
For cell-cycle exit analysis, the pregnant dam was injected with BrdU (50 mg/kg
b.w.) on E13. Fetuses were harvested 18 hr following the injection and the
heads were processed for BrdU/Ki-67 double immunolabeling. The fraction
of cells that had exited the cell cycle was estimated by counting the numberof BrdU+ cells in a 200 mm portion of the dorsal forebrain and the number of
BrdU+/Ki-67 cells in the same area. The cell-cycle exit fraction reported is
the number of BrdU+/Ki-67 cells divided by the total number of BrdU+ cells.
For analysis of the Tbr2 and Ctip2 population, the total number of Tbr2+ or
Ctip2+ cells in a 200 mm portion of the dorsal forebrain was counted. Care
was taken to ensure that the population analyzed was at a comparable
rostral/caudal and lateral/medial position in each of the samples. Analysis of
dorsal forebrain length consisted of measuring the length of the ventricular
surface from the pallial-subpallial border to the tip of cortical hem in sections
from a similar rostral/caudal position. For each untreated and atRA-treated
genotype, cell-cycle exit, Tbr2, Ctip2, and cerebral length analysis was per-
formed on sections from a minimum of three WT brains and three brains from
each mutant line from a minimum of two separate litters (nR 2).
Forebrain Explants and Meningeal Cultures
Detailed methods of explant methods and meningeal cultures are in the
Supplemental Data.
In Situ Hybridization
Raldh2 and Rdh10 in situ hybridization was performed as previously
described (Zarbalis and Wurst, 2000). ISH with Rdh10 was performed using
a 900 bases long DIG-labeled riboprobe comprising coding sequences
and 30UTR. DIG-labeled riboprobe for Raldh2 was transcribed from a plasmid
containing 937 bp of coding sequence and 30UTR kindly provided by Dr. John
L.R. Rubenstein.
Immunohistochemistry and X-Gal Staining
Whole embryo or whole head from E10.5–E16.5 were collected and fixed
overnight at 4C in 4% paraformaldehyde, cryoprotected, and frozen in
OCT. E18.5 heads were either fresh frozen in OCT or fixed as described above.
Tissue was cryosectioned in 12 mm increments. Immunostaining was per-
formed as described previously (Zarbalis et al., 2007) using the following
antibodies and concentrations: mouse anti-BrdU 1:50, BD Bioscience; rat
anti-BrdU 1:300, Novus; mouse anti-Tuj1 1:1000, Covance; rabbit anti-Zic
1:1500, gift from J. Aruga RIKEN Institute; rabbit anti-Raldh2 1:1000, gift
from P. McCaffery, University of Aberdeen; rabbit anti-Ki-67 1:300, LabVision;
rabbit anti-Tbr2 1:300, Chemicon; rat anti-Ctip2 1:800, Abcam; rabbit anti-
Brn2 1:200, Santa Cruz Biotechnologies; goat anti-Foxc1 1:300, Novus Bio-
logicals; goat anti-Foxc2 1:300, Novus Biologicals. For x-gal staining, heads
were fixed for 1 hr in 4% paraformaldehyde, cryoprotected, and cut in
25 mm increments. Sections were stained overnight with 1 mg/ml x-gal solution
(Sigma). All immunofluorescent and brightfield images were captured using
a Retiga CCD-cooled camera and associated QCapture Pro software (QImag-
ing Surrey). For quantification of the Par3 and aPKCl immunofluorescence,
the mean gray value was calculated using ImageJ software (NIH) and the
values were reported in the graphs as arbitrary units (a.u.). Analyzed images
were from three brains from at least two litters for each genotype/treatment
condition (nR 2).
Statistics
For pairwise analysis of treatment conditions and/or genotypes, Student’s t
tests were used. The standard errors of the mean (SEM) (±) are reported on
all graphs.Figure 7. In Vivo Rescue of Foxc1 Forebrain Phenotype by atRA
(A–H) Ctip2 (green) and Pax6 (red) immunostaining on E14.5 untreated (A, C, E, and G) and atRA-treated (B, D, F, and H) WT and Foxc1 mutants.
(I–L) Ctip2 immunostaining in untreated and atRA-treated WT (I), Foxc1h/h (J), Foxc1h/l (K), and Foxc1l/l (L) at E14.5. Dotted line indicates ventricular surface.
(M) Quantification of the dorsal forebrain length; values are a percentage of the mean length of untreated WT.
(N) Quantification of Ctip2+ cells in untreated and atRA-treated WT and Foxc1 mutant cortices.
(O–P) Nissl-stained E16.5 brains from untreated WT and Foxc1h/l and embryos exposed to an atRA diet (O). Adjacent sections immunolabeled for Ctip2 (red) and
Brn-2 (green) (P).
(Q–R) Nissl staining (Q) and Ctip2 (red) and Brn-2 (green) immunolabeling (R) from untreated and atRA diet E18.5 WT and Foxc1h/h brains.
(S) Schematic of cortical neuroepithelial divisions prior to (E11.5) and after (E14.5) the arrival of Raldh2/Rdh10-expressing cells (red cells) in the meninges.
Scale bars = 500 mm (A–H, O, and Q) and 100 mm (I–L, P, and R). *#, *, and **# indicate statistical significance (p < 0.05) from both untreated/atRA-treated WT and
atRA-treated Foxc1 mutants, untreated/atRA-treated WT, and untreated Foxc1h/l and Foxc1l/l, respectively. Error bars depict ± SEM.Cell 139, 597–609, October 30, 2009 ª2009 Elsevier Inc. 607
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